Voices
Joshua Schiffman Highlights AI x Cancer Omics Hackathon 2026 in Cambridge
Joshua Schiffman/X

Joshua Schiffman Highlights AI x Cancer Omics Hackathon 2026 in Cambridge

Joshua Schiffman, CEO and Co-Founder of Peel Therapeutics, shared on LinkedIn:

“Such a thrill to have been part of the AI x Cancer Omics Hackathon 2026 in Cambridge, UK. Highlight of the summer!”

Other articles about AI on OncoDaily.

AI in cancer AI in oncology AI x Cancer Omics Hackathon 2026 artificial intelligence cancer cancer data science cancer genomics Cancer Genomics Research cancer innovation Cancer Omics Cancer research Computational Oncology Joshua Schiffman OncoDaily Oncology oncology research Precision Oncology